APOIF 2017

Dear Colleagues,
 

Ophthalmic diseases have become one of the major killers of human health with at least dozens of ophthalmic diseases discovered globally by far.  Taking glaucoma and cataracts as examples, more than hundreds of millions of people worldwide are suffering from these two common eye diseases. Meanwhile, the proportion of myopia patients is rising with the popularity of various digital products. The number of mope in China is nearly 400 million, accounting for 1.5 times the global average. 
 

With a broadening of an aging population, global ophthalmic medical devices industry will maintain steady growth in recent years and the market size is expected to reach $46.3 billion by the year of 2022. Now the world's third largest market of ophthalmic medical devices, China and other Asia-pacific countries has enormous demand for advanced devices and innovative technologies. 
 

According to China 13th Five-Year Plan for national eye health, Chinese ophthalmic hospitals   are considered to have vast market potentials with steadily increased of market scale. As one of the medical segments, Ophthalmology had carried out an earlier exploration into marketization. In recent years, non-public ophthalmic hospitals have expanded continuously by virtue of flexible management, effective technology introduction and excellent market awareness. The rising number of people who suffer from ophthalmic diseases directly breeds the explosive market and presents enormous opportunities for ophthalmic drugs, medical instrument &equipment as well as medical treatment.  Over the next few years, Chinese ophthalmic hospitals market scale will remain at about 20%, and the market is expected to surpass 20 billion by the year of 2018. At the same time, motivated by the renewed sense of emerging & classic diseases, personalized & intelligent ophthalmology, 3D technology & minimal invasive techniques innovation, modern ophthalmology is developing rapidly. Tremendous progress has been made in ophthalmic diseases prevention &treatment and ophthalmology is facing with new development opportunities and challenges.
 

In such context, “Asia-Pacific Ophthalmology Innovation Forum 2017” (APOIF2017) will take place on April 22nd and 23rd, 2016 in Shanghai China. This forum will go with the theme of “Lightening the Future of Ophthalmology with Innovation & Technology Advancements”, global top hospitals representatives and leading ophthalmic surgeons will be invited to share the advanced surgery clinical experience of glaucoma, cataracts, ocular fundus, corneal diseases and ocular plastic. By then, 300+ senior representatives from government, societies, Public Hospitals, Non-public Medical Institutions, hospitals ophthalmic depts., research institutes, pharmaceutical companies, ophthalmic devices manufacturers, consulting agencies and investment enterprises will have  in-depth discussion of the trend and future development of Ophthalmology, hospital management and ophthalmologic disciplinary construction  as well as renewed clinical therapies, concepts and technology advancements. Geographically, besides the delegates from Mainland China, a large number will be traveling from Taiwan, Hong Kong, Japan, Singapore, Korea, Europe, the United States and many other countries/regions. Through the keynote speech, clinical case analysis, interactive panel discussion, equipment & products exhibition, the organizing committee is committed to provide emerging industry information, the modern ophthalmic clinical experience, extensive international cooperation opportunities etc. We are looking forward to meeting you at APOIF2017 this April in Shanghai!